Skip to main content

Advertisement

SpringerLink
Log in

Imaging of autoimmune hepatitis and overlap syndromes

  • Invited Article
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Autoimmune hepatitis (AIH) is an uncommon, chronic inflammatory, and relapsing liver disease of unknown origin that may lead to liver cirrhosis, hepatocellular carcinoma, liver transplantation, or death. AIH occurs in all age groups and races but can frequently manifest as acute fulminant hepatitis. Clinical presentation of AIH can have features similar to primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC), and these diseases may coexist leading to overlap syndromes. Although histological diagnosis is necessary, imaging features often can demonstrate characteristics that may be helpful to distinguish these diseases. Imaging features of AIH are those of chronic liver disease, and imaging plays important role in detection of complications and ruling out other possible causes of chronic liver disease. Emerging techniques such as elastography provide non-invasive options for diagnosis of significant fibrosis and cirrhosis during clinical follow-up as well as assessment of response to treatment. In this study, we will describe imaging findings in AIH and overlap syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ilyas JA, O’Mahony CA, Vierling JM (2011) Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 25:765–782

    Article  PubMed  Google Scholar 

  2. Bader TR, Beavers KL, Semelka RC (2003) MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226:675–685

    Article  PubMed  Google Scholar 

  3. Bilaj F, Hyslop WB, Rivero H, et al. (2005) MR imaging findings in autoimmune hepatitis: correlation with clinical staging. Radiology 236:896–902

    Article  PubMed  Google Scholar 

  4. Kobayashi S, Matsui O, Gabata T, et al. (2004) MRI findings of primary biliary cirrhosis: correlation with Scheuer histologic staging. Abdom Imaging 30:71–76

    Article  Google Scholar 

  5. Wenzel JS, Donohoe A, Ford KL 3rd, et al. (2001) Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign. Am J Roentgenol 176:885–889

    Article  CAS  Google Scholar 

  6. Grunwald D, Kothari D, Malik R (2014) Noninvasive markers in the assessment and management of autoimmune liver diseases. Eur J Gastroenterol Hepatol 26:1065–1072

    Article  CAS  PubMed  Google Scholar 

  7. Beuers U (2005) Hepatic overlap syndromes. J Hepatol 42(Suppl):S93–S99

    Article  PubMed  Google Scholar 

  8. Corpechot C, Gaouar F, El Naggar A, et al. (2014) Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology 146:970–979 (quiz e15-6)

  9. Corpechot C, Carrat F, Poujol-Robert A, et al. (2012) Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 56:198–208

    Article  PubMed  Google Scholar 

  10. Poupon R, Corpechot C (2011) Elastography-based assessment of primary biliary cirrhosis staging. Dig Liver Dis 43:839–840

    Article  PubMed  Google Scholar 

  11. Lewin M, Vilgrain V, Ozenne V, et al. (2009) Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology 50:528–537

    Article  PubMed  Google Scholar 

  12. Eaton JE, Dzyubak B, Venkatesh SK, et al. (2016) Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol 31:1184–1190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Gossard AA, Lindor KD (2012) Autoimmune hepatitis: a review. J Gastroenterol 47:498–503

    Article  CAS  PubMed  Google Scholar 

  14. Czaja AJ, Freese DK (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36:479–497

    Article  PubMed  Google Scholar 

  15. Montano Loza AJ, Czaja AJ (2007) Current therapy for autoimmune hepatitis. Nat Clin Pract Gastroenterol Hepatol 4:202–214

    Article  CAS  PubMed  Google Scholar 

  16. Wang Q, Yang F, Miao Q, et al. (2016) The clinical phenotypes of autoimmune hepatitis: a comprehensive review. J Autoimmun 66:98–107

    Article  PubMed  Google Scholar 

  17. Muratori P, Czaja AJ, Muratori L, et al. (2005) Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol 11:1862–1866

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bjornsson E, Talwalkar J, Treeprasertsuk S, et al. (2010) Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 51:2040–2048

    Article  PubMed  Google Scholar 

  19. Liberal R, Krawitt EL, Vierling JM, et al. (2016) Cutting edge issues in autoimmune hepatitis. J Autoimmun 75:6–19

    Article  CAS  PubMed  Google Scholar 

  20. Cole CD, Saxena R (2013) Autoimmune hepatitis. Surg Pathol Clin 6:259–276

    Article  PubMed  Google Scholar 

  21. Liberal R, Grant CR, Longhi MS, et al. (2014) Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev 13:435–440

    Article  CAS  PubMed  Google Scholar 

  22. Kogan J, Safadi R, Ashur Y, et al. (2002) Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol 35:75–81

    Article  PubMed  Google Scholar 

  23. Manns MP, Czaja AJ, Gorham JD, et al. (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51:2193–2213

    Article  CAS  PubMed  Google Scholar 

  24. Hoeroldt B, McFarlane E, Dube A, et al. (2011) Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center. Gastroenterology 140:1980–1989

    Article  PubMed  Google Scholar 

  25. Gatselis NK, Zachou K, Koukoulis GK, et al. (2015) Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 21:60–83

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gregorio GV, Portmann B, Reid F, et al. (1997) Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25:541–547

    Article  CAS  PubMed  Google Scholar 

  27. Teufel A, Weinmann A, Kahaly GJ, et al. (2010) Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 44:208–213

    Article  CAS  PubMed  Google Scholar 

  28. Czaja AJ (2013) Review article: the management of autoimmune hepatitis beyond consensus guidelines. Aliment Pharmacol Ther 38:343–364

    Article  CAS  PubMed  Google Scholar 

  29. Czaja AJ (2009) Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol 51:161–167

    Article  CAS  PubMed  Google Scholar 

  30. Montano-Loza AJ, Carpenter HA, Czaja AJ (2007) Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 46:1138–1145

    Article  CAS  PubMed  Google Scholar 

  31. Tripathi D, Neuberger J (2009) Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease. Semin Liver Dis 2009:286–296

    Article  Google Scholar 

  32. Faisal N, Renner EL (2015) Recurrence of autoimmune liver diseases after liver transplantation. World J Hepatol 7:2896–2905

    Article  PubMed  PubMed Central  Google Scholar 

  33. Vukotic R, Vitale G, D’Errico-Grigioni A, et al. (2016) De novo autoimmune hepatitis in liver transplant: state-of-the-art review. World J Gastroenterol 22:2906–2914

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Czaja AJ (2013) Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci 58:1459–1476

    Article  CAS  PubMed  Google Scholar 

  35. Wang QX, Shen L, Qiu DK, et al. (2011) Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis. Zhonghua Gan Zang Bing Za Zhi 19:782–784

    PubMed  Google Scholar 

  36. Obara N, Ueno Y, Fukushima K, et al. (2008) Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol 43:720–728

    Article  PubMed  Google Scholar 

  37. Andersson KL, Salomon JA, Goldie SJ, et al. (2008) Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 6:1418–1424

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kim TK, Jang HJ (2014) Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis. World J Gastroenterol 20:3590–3596

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sahni VA, Raghunathan G, Mearadji B, et al. (2010) Autoimmune hepatitis: CT and MR imaging features with histopathological correlation. Abdom Imaging 35:75–84

    Article  PubMed  Google Scholar 

  40. Qayyum A, Graser A, Westphalen A, et al. (2004) CT of benign hypervascular liver nodules in autoimmune hepatitis. Am J Roentgenol 183:1573–1576

    Article  Google Scholar 

  41. Cassani F, Valentini P, Cataleta M, et al. (1997) Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship with viremia. J Hepatol 26:479–483

    Article  CAS  PubMed  Google Scholar 

  42. Gutkowski K, Hartleb M, Kacperek-Hartleb T, et al. (2013) Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int 33:1370–1377

    Article  CAS  PubMed  Google Scholar 

  43. Singh S, Venkatesh SK, Wang Z, et al. (2015) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13(440–451):e6

    Google Scholar 

  44. Wang J, Malik N, Yin M, et al. (2016) Magnetic resonance elastography in autoimmune hepatitis. World J Gastroenterol

  45. Czaja AJ (2013) The overlap syndromes of autoimmune hepatitis. Digest Dis Sci 58:326–343

    CAS  PubMed  Google Scholar 

  46. Abdalian R, Dhar P, Jhaveri K, et al. (2008) Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 47:949–957

    Article  CAS  PubMed  Google Scholar 

  47. Hunter M, Loughrey MB, Gray M, et al. (2011) Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis. Ulster Med J 80:15–18

    PubMed  PubMed Central  Google Scholar 

  48. Gheorghe L, Iacob S, Gheorghe C, et al. (2004) Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur J Gastroenterol Hepatol 16:585–592

    Article  PubMed  Google Scholar 

  49. Chazouilleres O, Wendum D, Serfaty L, et al. (1998) Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28:296–301

    Article  CAS  PubMed  Google Scholar 

  50. Joshi S, Cauch-Dudek K, Wanless IR, et al. (2002) Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 35:409–413

    Article  CAS  PubMed  Google Scholar 

  51. Czaja AJ (1998) Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28:360–365

    Article  CAS  PubMed  Google Scholar 

  52. Boberg KM, Chapman RW, Hirschfield GM, et al. (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374–385

    Article  PubMed  Google Scholar 

  53. Czaja AJ (2013) Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol 27:417–423

    Article  PubMed  PubMed Central  Google Scholar 

  54. Perdigoto R, Carpenter HA, Czaja AJ (1992) Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 14:325–331

    Article  CAS  PubMed  Google Scholar 

  55. Hyslop WB, Kierans AS, Leonardou P, et al. (2010) Overlap syndrome of autoimmune chronic liver diseases: MRI findings. J Magn Reson Imaging 31:383–389

    Article  PubMed  Google Scholar 

  56. Vierling JM (2015) Autoimmune hepatitis and overlap syndromes: diagnosis and management. Clin Gastroenterol Hepatol 13:2088–2108

    Article  PubMed  Google Scholar 

  57. Liberal R, Grant CR, Mieli-Vergani G, et al. (2013) Autoimmune hepatitis: a comprehensive review. J Autoimmun 41:126–139

    Article  CAS  PubMed  Google Scholar 

  58. Zachou K, Muratori P, Koukoulis GK, et al. (2013) Review article: autoimmune hepatitis—current management and challenges. Aliment Pharmacol Ther 38:887–913

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA

    Neera Malik & Sudhakar K. Venkatesh

Authors
  1. Neera Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sudhakar K. Venkatesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sudhakar K. Venkatesh.

Ethics declarations

Funding

No funding was received for this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Statement of informed consent was not applicable since the manuscript does not contain any patient data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malik, N., Venkatesh, S.K. Imaging of autoimmune hepatitis and overlap syndromes. Abdom Radiol 42, 19–27 (2017). https://doi.org/10.1007/s00261-016-1019-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-016-1019-x

Keywords

Search

Navigation